False
August 20, 2026
6 min read
From multiple sclerosis to AI-driven discovery, Daniel Vitt reflects on the future of drug development
August 19, 2026
5 min read
Can iPSC platforms deliver consistent, commercial-scale cell therapies for large patient populations?
August 18, 2026
10 min read
From collapsing legacy models to the rise of Chinese biotech, industry leaders are being forced to rethink how drugs are developed, funded, and brought to market
August 14, 2026
4 min read
John Maher discusses the scientific and practical challenges of bringing CAR T-cell therapies to patients with solid tumors
False